Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Estonia to map DNA of over 10% of population
A trail-blazer in internet technology, cyber-savvy Estonia is rolling out a high-tech DNA database holding the genetic details of over 150,000 residents to improve the prevention, diagnosis and treatm...
Novo Nordisk sees clinical studies of stem cell-based therapies for type 1 diabetes in "next few years"
Novo Nordisk on Wednesday said that the first clinical studies of stem cell-based therapies for the treatment of type 1 diabetes could begin within the next few years, having achieved a key milestone ...
Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events
PHILADELPHIA and NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ.
Study finds old drug may help treat hereditary motor neuron disease
An already existing drug may help treat some cases of hereditary motor neuron disease (MND), a study has found.
Toothpaste ingredient may combat severe lung disease: Study
A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, when combined with an already approved drug, a study has found.
FDA Approves Doptelet
May 21, 2018 -- The U.
Statement from FDA Commissioner Scott Gottlieb, M.D., on the Trump Administration’s plan to lower drug prices
It is an important day in the Administration’s collaborative effort to address the rising cost of drugs.
Roche drug dramatically reduces bleeds in key hemophilia tests
LONDON (Reuters) - Roche’s new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting...
GSK’s blockbuster HIV drug linked with birth defects
Regulators in Europe and the US have issued warnings about a link between GlaxoSmithKline’s blockbuster HIV drug Tivicay (dolutegravir) and birth defects of the brain and spine.
Protein found in tobacco plant has potential to fight life-threatening infectious diseases
A team of scientists from Melbourne's La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases.
Johnson & Johnson scraps Alzheimer's trials on safety concerns
(Reuters) - Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer’s drug after observing safety issues, the latest drugmaker to abandon developing treatm...
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
The U.
440
441
442
443
444
445
446
447
448
